Greg D. Carmichael - 18 Apr 2022 Form 4 Insider Report for Encompass Health Corp (EHC)

Role: Director
Signature: /s/ Patrick Darby, attorney-in-fact for Mr. Carmichael
Issuer symbol: EHC
Transactions as of: 18 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 20 Apr 2022, 13:47:25 UTC
Previous filing: 18 Feb 2022
Next filing: 22 Apr 2022
SEC: View on sec.gov

Key filing fact

Greg D. Carmichael filed Form 4 for Encompass Health Corp (EHC) on 20 Apr 2022.

Key facts

This page summarizes Greg D. Carmichael's Form 4 filing for Encompass Health Corp (EHC).
1 reported transaction and 0 derivative rows are listed below.
Filing timestamp: 20 Apr 2022, 13:47.

Change

Previous filing in this sequence was filed on 18 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

EHC transaction

Encompass Health Common Stock

Award

Transaction value: $0
Shares: +20
Change %: +0.41%
Price: $0.000000
Shares after: 4,947
Date: 18 Apr 2022
Ownership: Direct
Footnotes: F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.

Content

Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On April 18, 2022, Encompass Health paid a dividend on its common stock of $0.28 per share and the closing price was $71.41. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.